Carfilnat 60 Mg Injection
In stock
Description
Carfilnat 60mg Injection (containing Carfilzomib) is a targeted cancer therapy used in the management of multiple myeloma. It functions as a proteasome inhibitor that blocks the degradation of proteins in cancer cells, leading to cellular stress and apoptosis.
Specifications
| Strength | 60 mg/vial |
|---|---|
| Active Ingredient: | Carfilzomib (60 mg/vial) |
| Storage | 2°C to 8°C |
| Administration | Intravenous (IV) Infusion |
| Formulation | Lyophilized powder (60 mg/vial |
| Drug Class | Proteasome Inhibitor |
